Merrimack Pharmaceuticals Inc logo

Merrimack Pharmaceuticals Inc

$ 4.16 0 (0%) 10:08 PM EST
P/E:
At Loss
P/B:
4.12
Market Cap:
$ 55.79M
Enterprise V:
$ 42.43M
Volume:
23.49K
Avg Vol (2M):
35.62K
Also Trade In:
Volume:
23.49K
Market Cap $:
55.79M
PE Ratio:
At Loss
Avg Vol (2-Month):
35.62K
Enterprise Value $:
42.43M
PB Ratio:
4.12
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Merrimack Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
One Broadway, 14th Floor, Cambridge, MA, USA, 02142
Description
Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.97
Interest Coverage No Debt
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -2.1
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 35.63
9-Day RSI 30.68
14-Day RSI 31.52
6-1 Month Momentum % -7.26
12-1 Month Momentum % 24.19

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 31.85
Quick Ratio 31.85
Cash Ratio 30.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.2

Financials (Next Earnings Date:2022-11-04 Est.)

MACK's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:MACK

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.12
Beta 1.03
Volatility % 50.99
14-Day RSI 31.52
14-Day ATR ($) 0.290185
20-Day SMA ($) 4.57433
12-1 Month Momentum % 24.19
52-Week Range ($) 3.66 - 7.41
Shares Outstanding (Mil) 13.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merrimack Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More